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A b s t r a c t
Optical coherence tomography (OCT) has opened new horizons for intravascular coronary imaging. It utilizes near-infrared 
light to provide a microscopic insight into the pathology of coronary arteries in vivo. Optical coherence tomography is also capa-
ble of identifying the chemical composition of atherosclerotic plaques and detecting traits of their vulnerability. At present it is 
the only tool to measure the thickness of the fibrous cap covering the lipid core of the atheroma, and thus it is an exceptional 
modality to detect plaques that are prone to rupture (thin fibrous cap atheromas). Moreover, it facilitates distinguishing between 
plaque rupture and plaque erosion as a  cause of acute intracoronary thrombosis. Optical coherence tomography is applied 
to guide angioplasties of coronary lesions and to assess outcomes of percutaneous coronary interventions broadly. It identi-
fies stent malapposition, dissections, and thrombosis with unprecedented precision. Furthermore, OCT helps to monitor vessel 
healing after stenting. It evaluates the coverage of stent struts by the neointima and detects in-stent neoatherosclerosis. With 
so much potential, new studies are warranted to determine OCT’s clinical impact. The following review presents the technical 
background, basics of OCT image interpretation, and practical tips for adequate OCT imaging, and outlines its established and 
potential clinical application. 
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Introduction
Optical coherence tomography (OCT) is the latest de-
velopment in intravascular coronary imaging. Similarly to 
intravascular ultrasound (IVUS), OCT provides cross-sec-
tional images of the vessel. However, instead of sound, OCT 
employs light for tissue analysis that enables visualization 
of the coronary lesions with almost microscopic precision 
[1, 2]. Optical coherence tomography was developed by 
Huang et al. at the Massachusetts Institute of Technolo-
gy. They first demonstrated ex vivo imaging of the retina 
and atherosclerotic plaque in 1991 [3]. Brezinski et al. were 
the first to suggest intravascular application of OCT. In an 
ex vivo study [4] they confirmed the ability of OCT to de-
tect with sufficient resolution intimal cap layers associated 
with unstable plaque. Subsequently they developed a fi-
beroptic-based catheter that was first used in animals [4].
High-resolution images of OCT allow identification of 
the morphology of atherosclerotic plaque and have the 
potential to detect its chemical composition [5]. More-
over, OCT is uniquely capable of guiding percutaneous 
coronary interventions (PCI) and assessing their out-
comes [6]. As recently reported, OCT-guided PCI brought 
benefit for patients’ treatment as compared to PCI guid-
ed by angiography alone [7]. However, to benefit the 
most from OCT imaging, it is essential to understand the 
principles of OCT, to develop an appropriate technique of 
imaging, and to become familiar with the basics of image 
interpretation. 
Principles of optical coherence tomography
Optical coherence tomography is a near-infrared (nIR) 
light based imaging modality whose central wavelength 
of light ranges from 1250 to 1350 nm. It measures an 
interference signal of the nIR light backscattered from 
the analyzed tissue with the light backscattered from the 
reference mirror. The frequency of the interference signal 
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corresponds to the depth of the analyzed tissue. There 
are two approaches to analyze the interference signal 
of nIR: a time-domain (TD) slow analysis and a frequen-
cy-domain (FD) fast analysis. Time-domain analysis mea-
sures the alteration of the interference signal derived 
by one wavelength of nIR light at a time. Conversely, FD 
analysis using Fourier transformation measures the in-
terference signal of the whole spectrum of nIR light at 
a single time point [2]. Introduction of FD analysis was 
a key milestone toward clinical viability of intravascular 
OCT as it significantly decreased the time of OCT imag-
ing and eliminated the need to temporarily occlude the 
investigated segment in order to clear it from the blood. 
Therefore, current systems of intravascular OCT imaging 
employ only FD analysis.
The OCT probe is composed of a  signal generator 
(light source) (“swept laser”), a detector and a reference 
fixed mirror. nIR light travels from the light source to the 
probe via an optical fiber, and the probe directs the light 
outwards and perpendicular to the catheter. The probe 
rotates with the frequency of 100 rounds/s, which allows 
acquisition of 50 000 axial lines of the signal/s.
The use of light enables OCT to provide high-resolu-
tion images (10–20 μm) of the vessel wall as compared to 
images obtained by IVUS (100 μm). Nevertheless, the use 
of light generates particular limitations in its application 
to intravascular imaging. The blood cells cause multiple 
scattering of nIR light and its high signal attenuation; as 
a consequence OCT imaging technique requires blood re-
moval out of the vessel during imaging. In addition, nIR 
light has limited penetration into the vessel wall and ob-
tains a signal only from 1 to 3 mm in depth. Such a low 
penetration of the light beam hampers a full assessment 
of the plaque. In contrast, IVUS is able to penetrate up to 
8 mm deep into the tissue [8].
Technique of optical coherence 
tomography imaging
The OCT system consists of three elements: an intra-
coronary OCT catheter, a dock, and a console to acquire 
and review images and perform measurements. An offline 
workstation for image analysis may also be available.
At present, all available systems require at least 
a 6 Fr size guiding catheter to advance the OCT catheter 
into the coronary artery. The guiding catheter used for 
OCT imaging should not contain side holes and should 
provide a stable support.
The OCT catheter contains a  rotating probe inside 
to emit nIR light and detect the backscattered light. 
Like most contemporary coronary equipment, the OCT 
catheter is a  rapid exchange delivery system, which is 
advanced into the coronary artery over a standard cor-
onary guidewire (0.014”). There are two types of OCT 
catheters: the Dragonfly Intravascular Imaging Cathe-
ter and the Dragonfly Duo OCT Imaging Catheter. There 
are two radiopaque markers at the tip of the Dragonfly 
Intravascular Imaging Catheter and the probe placed 
7 mm proximally to the proximal one, and there are three 
radiopaque markers at the tip of the Dragonfly Duo In-
travascular Imaging Catheter, of which the middle one is 
the probe (Figure 1).
The OCT catheter is connected to the OCT console 
by the dock, and the dock operates an automatic pull-
back of the probe inside the catheter. A single pullback 
is performed with a speed of 20 mm/s and lasts 2.7 s. 
It allows imaging of up to 72 mm of the vessel during 
a single run of the probe. Such a fast pullback of the OCT 
probe significantly reduces the bias caused by cardiac 
movement. 
The OCT imaging requires blood removal from the 
vessel at the time of the pullback. Therefore, the previous 
generation of TD-based OCT imaging required occlusion of 
the vessel at the time of imaging, which increased the risk 
of ventricular fibrillation. The new FD-based OCT imaging 
does not require occlusion of the vessel anymore, and thus 
the risk of life-threatening arrhythmias is significantly re-
duced [1]. The blood inflow into the vessel is sufficiently 
restricted by the contrast injection into the artery at the 
time of the pullback. The contrast may be injected either 
manually or using an automatic injector. The setting for 
the automatic injection is as follows: flow speed = 4 ml/s, 
volume = 14 ml, pressure = 400 PSI and rise time = 0s. It 
is also important to flush the blood away from the OCT 
catheter before the pullback of the probe starts; a small 
syringe filled with contrast is used for that. The presence 
of blood in the OCT catheter or in the lumen of the vessel 
disqualifies acquired images from the analysis (Figure 1).
The pullback of the OCT probe starts automatically 
following the contrast injection. When the pullback is fin-
ished, the OCT probe returns to its initial position and 
the catheter may be removed from the vessel. Due to the 
ultrafast OCT catheter’s pullback, all acquired images are 
reviewed and analyzed off-line.
Image analysis
Normal coronary artery morphology
In a healthy vessel OCT visualizes three layers of the 
artery: an internal elastic lamina (an abluminal bright, 
high reflective line), a media (a dark, low-reflective line) 
and an external elastic lamina (an adluminal high reflec-
tive zone). Beyond the external elastic lamina, OCT ex-
poses an adventitia with its vasa vasorum (Figure 2).
Atherosclerosis
The OCT imaging offers a  possibility to distinguish 
lipid-rich, calcified and fibrotic lesions. The analysis of 
the plaque composition is based on its homogeneity, 
reflectivity and demarcation from other structures. Lip-
id deposition is characterized by diffuse edges with high 
reflectivity and high attenuation. Calcium features sharp 
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edges with low reflectivity and low attenuation. Fibrot-
ic components of the plaque are visualized as a homo-
geneous, low-attenuated zone with high reflectivity. It 
is also possible to detect cholesterol clefts in the vessel 
as irregular bright zones. Interestingly, some histological 
studies indicated that bright spots with high reflectivity 
and uneven shadowing might represent the agglomera-
tion of macrophages in the vessel wall (Figure 2) [9].
In addition to the analysis of the plaque composition, 
OCT is also able to detect white and red thrombus inside 
the arterial lumen. The white thrombus appears as an ir-
regular structure of high reflectivity and low attenuation 
of the signal, and the red thrombus is shown as an irreg-
ular structure of low reflectivity and high attenuation of 
the signal (Figure 3).
Quantitative assessment of the lesion 
Optical coherence tomography images demarcate 
the lumen of the vessel clearly. Thus, the incorporated 
algorithm allows fast semi-automatic measurement of 
its diameter and area. As compared to IVUS, OCT pro-
vides a smaller area and a shorter diameter of the artery 
A
C
B
D
Figure 1. Positioning of the OCT catheter and calibration of the system. Location of the lens in relation to prox-
imal marker (PM) and distal marker (DM) under fluoroscopy for (A) Dragonfly Intravascular Imaging Catheter 
and for (B) Dragonfly Duo OCT Imaging Catheter. C – Perfect Z-offset to obtain accurate measurements – the 
blue line should be positioned at the edges of the catheter. D – No blood inside the OCT catheter. In the lower 
right corner the insert illustrates blood appearance inside the catheter
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lumen. The difference falls in a range between 10% and 
20% [10, 11]. In addition, an autopsy study demonstrat-
ed that OCT measurements correlate well with those 
obtained by histopathology, and that OCT estimates of 
the size of the vessel lumen are closer to those obtained 
from histopathology than IVUS-derived measurements: 
28% vs. 40% respectively [12]. It should be noted that 
perfect calibration of the OCT system is required to ob-
tain reliable measurements, which is based on the size of 
the OCT probe (Z-offset) (Figure 1).
The assessment of the artery at its proximal or distal 
reference segment helps to estimate the length of the le-
sion and its percentage stenosis. However, OCT provides 
only the geometric assessment of the disease and can-
not be used to determine the functional significance of 
a stenosis. A study which compared OCT results against 
values of the fractional flow reserve suggested that a lu-
men area of less then 1.9 mm2 correlated with significant 
myocardial ischemia [13].
Unfortunately, the limited penetration into the vessel 
wall hinders quantification of the plaque burden (the pro-
portion of a plaque that occupies the vessel). However, 
the transverse extent of either the lipid core or the cal-
cium core in the vessel can serve as a surrogate for the 
plaque burden. They are expressed in degrees and termed 
as the lipid arc or calcium arc respectively (Figure 2).
Vulnerable plaque detection
Optical coherence tomography is now a gold standard 
to detect vulnerable plaques that are prone to rupture. 
Such plaques present with the following features: a thin 
fibrous cap (< 65 μm), a lipid rich core, neovascularization, 
and macrophage infiltration [14, 15]. All these features 
are reliably detectable by OCT, and especially the precise 
measurement of the thin fibrous cap is now possible due 
to OCT’s superior resolution (Figure 3) [5, 16, 17].
Clinical applications
Stent size selection
Optical coherence tomography measurements of the 
vessel lumen facilitate selection of the appropriate stent 
diameter and length required for PCI. Two techniques 
have been reported to obtain a reference for stent diam-
eter by OCT, which are similar to IVUS guidance: one re-
fers to the average “media to media” diameter and the 
other to the average diameter of the lumen. So far, there 
have been no reports of long-term outcomes that would 
A
D
B
E
C
F
Figure 2. Representative OCT images of a healthy vessel and fibrotic, calcified, lipid-rich and thin fibrous cap 
atheroma. A – Healthy vessel: lumen (L), vessel wall (W), and adventitia (AD) with vasa vasorum (V). B – Three 
layers of the vessel: internal elastic lamina (IEL), media (M) and external elastic lamina (EEL). C – Fibrotic ather-
oma (Fi). D – Lipid-rich plaque (LR) with lipid arc = 190° and bright spots (BS). E – Calcified atheroma (Ca) with 
calcium arc = 93°. F – Lipid-rich plaque with cholesterol clefts (Ch)
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Figure 3. Thrombus and structures within the plaque by OCT. A – Red thrombus (RT). B – White thrombus (WT). 
C – Thrombus inside the vessel without ruptured plaque, which suggests plaque erosion. D – Thin fibrous cap 
(40 μm, white arrows) covers the lipid-rich core (LR) (TCFA – thin cap fibrous atheroma). E – A ruptured lipid-rich 
plaque (RP). F – Neovascularization of the plaque (white arrows indicate small vessels)
clearly demonstrate whether either of these approaches 
is superior.
Strategy for calcified lesions
The OCT-derived morphology of the plaque may help 
to select the best strategy for PCI. As it was reported by 
IVUS studies, almost 65% of calcified lesions cannot be 
detected by angiography alone [18]. Since OCT is able to 
detect a calcified lesion with the same accuracy as IVUS 
[19], its results may serve as an indication for the use of 
a high-pressure balloon or rotablation to facilitate PCI of 
calcified lesions.
Prediction of peri-procedural complications
The prediction of peri-procedural complications may 
help increase patients’ safety and decrease costs of the 
procedure and the time of hospitalization. Previous re-
ports stated that OCT-detected thin cap fibrous athero-
ma (TCFA) was a predictor of the no-reflow phenomenon 
and a peri-procedural myocardial infarction [20, 21]. The 
reported prevalence of microvascular obstruction and the 
no-reflow phenomenon was directly proportional to the 
size of the lipid arc and inversely related to fibrous cap 
thickness [22]. 
Furthermore, OCT imaging may monitor the optimal 
elimination of thrombus out of the infarct-related artery, 
and also facilitates identification of the plaque rupture 
responsible for ST-segment elevation myocardial infarc-
tion (STEMI). The presence of the thrombus in the lumen 
and the rupture plaque is a risk factor of the no-reflow 
phenomenon as well (Figure 3) [23].
Treatment of eroded plaques
Previous histological studies have reported that erod-
ed (not ruptured) plaques cause almost 40% of STEMI 
[15]. Those eroded plaques are mostly fibrotic ones with 
endothelial denudation on their surface. Interestingly, 
most eroded plaques are neither lumen-narrowing nor 
lipid-rich ones, and thus they may be treated without 
stent placement. 
Optical coherence tomography imaging is able to dif-
ferentiate between plaque rupture and plaque erosion 
as the cause of intravascular thrombogenesis. Therefore, 
OCT-diagnosed plaque erosion may suggest performing 
only thrombectomy without stenting in the infarct-relat-
ed artery. It is a novel concept of STEMI treatment, but 
the results from a  small group of patients are promis-
ing. The patients with OCT-diagnosed eroded plaque 
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and subjected only to thrombectomy without stenting 
did not report any major adverse cardiac events during 
median 735 days follow-up (Figure 3) [24]. Whether the 
OCT-guided reduction of stent use may translate into re-
duction of plaque/thrombus disruption and subsequent 
microembolization/no-reflow remains to be elucidated.
Imaging of percutaneous coronary intervention 
outcomes
Optical coherence tomography is irreplaceable in 
terms of immediate and long-term analysis of PCI out-
comes. Due to its high resolution it enables unparalleled 
insight into stent apposition and its expansion. It also 
detects, with unprecedented precision, the stent edge 
dissections, protrusion of the plaque through struts and 
in-stent thrombosis. 
Stent struts are defined as well embedded in the 
vessel wall, protruding to the lumen out of the vessel 
wall, or malapposed when stent struts do not touch 
the vessel wall. Since OCT is only available to detect 
the adluminal edge of struts, the diagnosis of stent 
malapposition is based on the distance between the 
adluminal edge of the stent strut and the vessel wall. 
If the distance between the edge of the strut and the 
vessel wall is more than the thickness of the strut for 
bare metal stents (BMS) or if it is more than the total 
thickness of the strut plus the thickness of the polymer 
for drug-eluting stents (DES), it indicates malapposition. 
A distance longer than 160 μm suggests malapposition 
for most stents.
The extent of the malposition is defined by its arc 
(similar to a lipid arc) and by its length (Figure 4). Small 
malappositions are covered by the neointima and do not 
require any correction [25]. However, a significant malap-
position (> 200 μm) is a  risk factor of acute in-stent 
thrombosis (Figure 4) [26, 27].
Early after stent implantation, OCT is also able to de-
tect the plaque protrusion through stent struts. It fea-
tures a smooth surface with high signal attenuation (Fig-
ure 4). Tissue protrusion is mostly observed in the lesion 
responsible for acute coronary syndromes because such 
lesions are replete with lipid [28]. It has been document-
ed to be an independent predictor of peri-procedural 
myocardial infarction [21].
Furthermore, unlike IVUS and angiography, OCT is 
very sensitive to detect dissection of the vessel [29]. Pre-
A
D
B
E
C
F
Figure 4. Post-procedure outcomes of percutaneous coronary intervention by OCT. A – Malapposition of stent 
struts (malapposition arc = 65°). B – The stent in the previously implanted stent. C – The bioabsorbable stent 
scaffold. D – Coronary bifurcation (MB – main branch, SB – side branch). E – Coronary artery’s dissection with 
visible true (TL) and false vessel lumen (FL), and the entry of the dissection (DE). F – Plaque protrusion (PP) 
after stent implantation
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liminary observation indicated that dissections which are 
not lumen-narrowing, are limited to intima, and are less 
than 2.5 mm long may be left untreated (Figure 4) [29].
Follow-up of percutaneous coronary 
intervention outcomes
Optical coherence tomography reveals the coverage 
of stent struts by the neointima and detects uncovered 
stent struts [30]. The OCT-derived area of the neointi-
ma correlates very well with the histology, with values 
only about 6.3% smaller [31]. Uncovered stent struts 
are also a strong risk factor of in-stent thrombosis (Fig-
ure 4) [32]. 
Moreover, OCT not only precisely quantifies the neoin-
tima over the stent struts but also provides insights into 
its composition. The analysis of the neointima’s compo-
sition may reveal deposition of lipids, which indicates in-
stent neoatherosclerosis [33]. In-stent neoatherosclerosis 
occurs in both DES and BMS and may also present as 
TCFA [34]. Such neoatheromas, like typical atheromas, 
may rupture and cause acute in-stent thrombosis. Inter-
estingly, recent OCT studies demonstrate that some neo-
atheromas evolve into calcifications located inside of the 
stent (Figure 5) [35].
Imaging of bioabsorbable vascular scaffolds
Bioresorbable vascular scaffolds (BVS) are not radi-
opaque and their assessment is limited under fluorosco-
py after the implantation. Fortunately, nIR light backscat-
ters from the implanted BVS and thus OCT presents with 
histology-like precision in its entire footprint (as opposed 
to only linear reflection of the adluminal surface of the 
metallic stent struts (Figure 4 C vs. 4 B), apposition and 
its expansion [36]. Moreover, it can monitor vessel heal-
ing and absorption after implantation [37]. Progress in 
absorption of the scaffold is much better visible in OCT 
than in IVUS [38]. 
Guidance for percutaneous coronary 
intervention of bifurcations
Optical coherence tomography is also used to guide 
bifurcation stenting. The benefit of OCT is to image the 
position of the guidewire, which is advanced through 
stent struts into the side branch [39]. It is best visualized 
by the three dimensional reconstruction of OCT images, 
which is still investigational [40]. If the guidewire is po-
sitioned close to the carina, the best apposition of stent 
struts is achieved by the “kissing balloon” technique. 
A
D
B
E
C
F
Figure 5. Late outcomes of percutaneous coronary intervention by OCT. A – Covered struts in malapposition. 
B – Underexpansion of the stent. C – Chronic vessel dissection; true lumen (TL), false lumen (FL). D – Heteroge-
neous neointima in the stent (arrow indicates stent strut). E – Thin fibrous cap covering neoatheroma (50 μm); 
F – Plaque protrusion after balloon angioplasty in the restenotic stent
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After the bifurcation stenting, OCT presents the 
shape of the carina and detects the malapposition of 
stent struts. Note that PCI of bifurcations is an inde-
pendent risk of malapposition and in-stent thrombosis; 
hence the precise guidance by OCT can reduce the risk 
(Figure 5) [41].
Identification of transplant vasculopathy
The prevalence of coronary vasculopathy (CAV) is al-
most 50% after heart transplantation in the 5-year fol-
low-up. Due to denervation of the transplanted heart, 
anginal symptoms of CAV are not obvious and the care 
of patients after the heart transplant has to be extremely 
vigilant. Therefore, coronary angiography is repeated an-
nually to screen for CAV. Nevertheless, angiography alone 
is limited to detect such vasculopathy because CAV is 
usually diffused across coronary arteries and may not 
manifest under fluoroscopy as obstructive disease, while 
in fact causing coronary flow impairment and ischemia. 
Due to its superior resolution, OCT features higher 
sensitivity in detection of CAV as compared to angiog-
raphy and allows quantification of intimal and medial 
thickening. Moreover, it is able to map lipid deposits in 
coronary arteries of the transplanted heart [42]. Howev-
er, future studies are warranted to determine the pre-
dictive clinical value of that OCT-derived information. If 
OCT detects lipid-rich plaques in CAV, it may be used to 
stratify patients to aggressive lipid-lowering therapy in 
order to prevent silent coronary disease syndromes [43].
Optical coherence tomography  
in extracoronary vasculature
Although OCT has been primarily used in coronary 
vasculature, reports are available for other vascular beds 
too. Yoshimura et al. [44] studied a population of patients 
with carotid artery stenosis and compared OCT vs. IVUS 
results in these vessels [45]. 
Similarly, OCT was used for evaluation of lower limb 
vessels – both femoro-popliteal [46] and below-the-knee 
[47] arteries. Other applications include imaging of radi-
al arteries [48] and visualization of intimal thickening of 
pulmonary arteries in patients with pulmonary hyperten-
sion [49].
Limitations of optical coherence 
tomography
First of all, an additional volume of contrast is un-
avoidable for OCT imaging, and hence it should be ap-
plied in patients with renal insufficiency carefully. Sec-
ondly, effective contrast injection requires the guiding 
catheter to intubate the coronary ostium, and that limits 
the analysis of ostial lesions. Thirdly, OCT image analysis 
is not free from artifacts, and therefore its results depend 
strongly on the observer’s experience. Finally, limited nIR 
light penetration depth hinders OCT application in ves-
sels of more than 10 mm in diameter and impedes the 
comprehensive analysis of the plaque burden in the pres-
ence of significant positive remodeling where the exter-
nal elastic lamina is quite remote from the lumen edge.
Pros and cons of optical coherence 
tomography as compared to intravascular 
ultrasound
Still, there is a lively discussion between proponents 
and opponents of these two intravascular methods. Ad-
vantages of OCT are its high resolution, fast pullback of 
the OCT probe, the high accuracy of the plaque compo-
sition assessments [5] and the impressive assessment 
of implanted stents. However, its disadvantages are the 
additional contrast injection, the lack of ostial lesion 
imaging, and low tissue penetration that impedes the 
quantification of plaque burden. These limitations may 
be overcome by IVUS that complements OCT imaging, 
and technology development is underway to develop hy-
brid systems combining both modalities in one catheter. 
Despite low image resolution, IVUS penetrates deeper 
into the vessel wall and enables quantification of the 
plaque burden in a  broader range of vessel calibers. 
Moreover, IVUS imaging does not require additional con-
trast injection and thus is friendlier logistically and in 
the setting of renal compromise, as well as more suit-
able for the assessment of ostial lesions. Nevertheless, 
low resolution of IVUS imaging does not match the OCT 
capability to measure the thickness of the fibrous cap 
covering the lipid core, neointimal stent strut coverage 
or to detect luminal dissections and thrombus. Although 
radio-frequency analysis of the IVUS signal claims to be 
able to characterize plaque composition, its accuracy is 
controversial [50]. 
Conclusions
Optical coherence tomography provides a  new in-
sight into the pathology of coronary artery disease in vivo 
and is irreplaceable to assess the immediate and long-
term outcomes of PCI. It is broadly applied to assess the 
vessel healing after stent implantation. Moreover, in the 
near future, it may change the strategy of interventions 
for eroded plaque and improve the follow-up of patients 
after heart transplantation. With so much diverse infor-
mation provided by OCT, further studies are warranted 
to determine its long-term clinical impact and predictive 
value in patients with atherosclerotic disease. 
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